Olmesartan blocks advanced glycation end products-induced vcam-1 gene expression in mesangial cells by restoring Angiotensin-converting enzyme 2 level.
Y Ishibashi, T Matsui, S Yamagishi
Index: Horm. Metab. Res. 46(6) , 379-83, (2014)
Full Text: HTML
Abstract
Advanced glycation end products (AGEs) and their receptor (RAGE) system are involved in diabetic nephropathy. Angiotensin-converting enzyme 2 (ACE 2) plays a protective role against cardiovascular and renal injury by stimulating the production of angiotensin-(1-7) [Ang-(1-7)], an antagonist of angiotensin II (Ang II). However, effects of the AGEs-RAGE axis on ACE 2 expression in mesangial cells remain unknown. We examined here the role of ACE 2 in the AGEs-RAGE-induced mesangial cell damage and investigated whether olmesartan, one of the Ang II type 1 receptor blockers (ARB), prevented the deleterious effects of AGEs via restoration of ACE 2 and Ang-(1-7) level. AGEs significantly increased superoxide generation, upregulated RAGE mRNA level, and decreased ACE 2 gene expression and Ang-(1-7) production in mesangial cells, all of which were blocked by olmesartan, but not by a different type of ARB, azilsartan. An antioxidant, N-acetylcysteine or RAGE-antibodies also restored the decrease in ACE 2 mRNA level in AGEs-exposed mesangial cells. Moreover, olmesartan, but not azilsartan completely inhibited the AGEs-induced increase in vascular cell adhesion molecule-1 (VCAM-1) mRNA level in mesangial cells, which was abolished by the treatment with A-779, an antagonist of Ang-(1-7) receptor, Mas receptor. Our present study suggests that olmesartan could block the AGEs-induced VCAM-1 gene induction in mesangial cells by restoring the downregulated ACE 2 levels and subsequently stimulating the Ang-(1-7)-Mas receptor axis. Restoration of ACE 2 levels and blockade of renin-angiotensin system by olmesartan might be a promising strategy for the treatment of diabetic nephropathy. © Georg Thieme Verlag KG Stuttgart · New York.
Related Compounds
Related Articles:
Ellipticine induces apoptosis in T-cell lymphoma via oxidative DNA damage.
2015-03-01
[Leuk. Lymphoma 56(3) , 739-47, (2015)]
2014-11-01
[Pigment Cell Melanoma Res. 27(6) , 1051-62, (2014)]
Antiviral effect of methylated flavonol isorhamnetin against influenza.
2015-01-01
[PLoS ONE 10(3) , e0121610, (2015)]
2015-02-01
[Mol. Med. Report. 11(2) , 1428-34, (2014)]
Mechanism of Dose-Dependent Regulation of UBE1L by Polyphenols in Human Bronchial Epithelial Cells.
2015-08-01
[J. Cell. Biochem. 116 , 1553-62, (2015)]